Comprehensive analysis of Glass AI's strengths and weaknesses based on real user feedback and expert evaluation.
Bundles ambient scribing and clinical decision support in one subscription, replacing what would otherwise require two separate tools (typically $150-$400/month combined)
Pro tier at $90/month is competitive against standalone AI scribe products and includes unlimited usage of both scribing and decision support
Available on iOS, Android, and web, letting clinicians capture encounters on a phone in the exam room and review notes from a desktop later
Evidence-based diagnostic suggestions are grounded in current medical literature, helping clinicians consider comprehensive differentials for atypical or complex presentations
Educational value for medical residents and students — the structured problem-representation-to-differential workflow mirrors how clinical reasoning is formally taught
Max tier ($200/month) adds direct EHR integration so AI-generated notes flow into the chart without copy-paste
6 major strengths make Glass AI stand out in the coding agents category.
Restricted to licensed healthcare professionals — patients and non-clinical users cannot access the platform for self-diagnosis or general health questions
Specialty depth varies: well-suited to general internal medicine, family medicine, and emergency medicine, but may underperform on rare diseases or narrow subspecialties (e.g., advanced oncology subtypes, rare genetic disorders)
EHR integration is gated behind the $200/month Max tier — Pro users must still copy notes manually into their charting system
Output quality is bounded by the quality of clinician input: incomplete histories or vague problem representations produce weaker differentials
HIPAA and institutional compliance review is typically required before clinics can deploy ambient scribing on real patient encounters, adding rollout friction
5 areas for improvement that potential users should consider.
Glass AI has potential but comes with notable limitations. Consider trying the free tier or trial before committing, and compare closely with alternatives in the coding agents space.
If Glass AI's limitations concern you, consider these alternatives in the coding agents category.
Ada Health delivers AI-powered symptom assessment that walks users through a structured medical interview, identifies probable conditions, and recommends next steps ranging from self-care to emergency attention.
AI-powered clinical documentation platform that automatically captures patient conversations and generates comprehensive medical records, reducing physician documentation burden by up to 85%
AI-powered digital pathology platform providing FDA-cleared diagnostic tools, biomarker analysis, and enterprise workflow management for laboratories and biopharma companies.
Glass Health offers three tiers per its published schema: a Free plan with limited clinical decision support, a Pro plan at $90/month with unlimited ambient scribing and unlimited clinical decision support, and a Max plan at $200/month that adds direct EHR integration on top of everything in Pro. The free tier is suitable for residents and students experimenting with the platform, while solo clinicians and small practices typically land on Pro. Max is targeted at clinicians whose workflow depends on notes flowing directly into Epic, Athena, or another EHR without manual copy-paste.
Glass AI is positioned as a clinical decision support tool, not a diagnostic device — every output is intended to assist a licensed clinician's reasoning, never to replace it. The platform explicitly emphasizes that all diagnostic and treatment decisions must be made by qualified healthcare providers using the full clinical context, patient history, and applicable standards of care. Healthcare institutions should review Glass's regulatory and compliance posture directly with the company before deploying it in clinical workflows. Individual clinicians remain responsible for verifying any AI-generated suggestion against current guidelines.
Glass's ambient scribe captures the audio of a patient encounter and generates a structured clinical note (typically SOAP-format) that the clinician can review, edit, and finalize before signing. The mobile apps on iOS and Android make it practical to use a phone as the recording device in the exam room. Glass markets itself to clinicians who must operate under HIPAA, but specific Business Associate Agreements (BAAs), data retention policies, and audit logs should be confirmed directly with Glass Health before patient-identifiable audio is processed. Most institutions require a security review prior to enabling ambient scribing on real encounters.
Yes — Glass is widely used by medical students and residents as a clinical reasoning learning tool, and the free tier provides enough access to practice differential generation on cases. The platform's problem-representation-to-differential format mirrors how clinical reasoning is formally taught in medical school and residency, making it a useful complement to case-based curricula. Trainees should still use Glass under attending supervision and treat its output as a study aid rather than a substitute for clinical training, the way one would use UpToDate or DynaMed.
Compared to the other AI Healthcare tools in our directory, Glass is one of the few that bundles ambient scribing with active clinical decision support in a single product — most scribe-only competitors like Nuance DAX or Abridge focus on note generation alone, often at premium per-provider pricing through enterprise contracts. Glass's $90/month Pro tier is notably more accessible to solo clinicians and small practices than enterprise scribe contracts, which can run several hundred dollars per provider per month. If you only need a scribe and you're already inside a large health system with a Nuance/Microsoft contract, DAX may integrate more deeply; if you want decision support plus scribing on a transparent monthly subscription, Glass is the more flexible option.
Consider Glass AI carefully or explore alternatives. The free tier is a good place to start.
Pros and cons analysis updated March 2026